A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
NCT00400608 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2016-10-28
Summary
Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA
Conditions
Interventions
- DRUG
-
ADVAIR HFA
- DRUG
-
ADVAIR DISKUS
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Completion
- 2007-02-28
Countries
- United States
Study Locations
More Related Trials
-
Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT
NCT01476059 ·Status: COMPLETED ·Phase: PHASE4
-
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
NCT00441441 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Of Symptomatic Asthma In Children
NCT00197106 ·Status: COMPLETED ·Phase: PHASE4
-
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
NCT00385463 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old
NCT01848769 ·Status: COMPLETED ·Phase: PHASE2
-
MGR001 / Advair Diskus Local Equivalence Study in Asthma
NCT02245672 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
NCT00118716 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive
NCT06433908 ·Status: COMPLETED ·Phase: PHASE1
-
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
NCT00395304 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
NCT01453023 ·Status: COMPLETED ·Phase: PHASE2
-
Montelukast With Status Asthmaticus, Ages 6-18
NCT00494572 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
NCT02301975 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of E004 in Children With Asthma
NCT01460511 ·Status: COMPLETED ·Phase: PHASE3
-
Individualized Therapy For Asthma in Toddlers
NCT01606306 ·Status: COMPLETED ·Phase: PHASE3
-
Albuterol HFA MDI in Pediatric Participants With Asthma
NCT00577655 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
NCT00118690 ·Status: COMPLETED ·Phase: PHASE4
-
Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA
NCT05018598 ·Status: TERMINATED ·Phase: PHASE4
-
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
NCT01475721 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial
NCT02061280 ·Status: COMPLETED ·Phase: PHASE4
-
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
NCT00867737 ·Status: UNKNOWN ·Phase: PHASE4
-
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
NCT01147744 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma
NCT00452348 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)
NCT01258803 ·Status: COMPLETED ·Phase: PHASE2
-
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
NCT01147848 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
NCT01136655 ·Status: COMPLETED ·Phase: PHASE2